ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,509.01
      0.62%
      US Tech 100
      19,460.00
      0.95%
      Dow Jones
      39,331.85
      0.41%
      Brent Oil
      86.555
      0.13%
      Bitcoin
      60,867.27
      -1.87%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ascendis Pharma AS (ASND)

      7. Ascendis Pharma AS (ASND) News

      Ascendis Pharma AS

      Ascendis Pharma AS (ASND)

      ASN Duurzaam Aandelenfonds Inc
      Ascendant Resources Inc
      136.27
      2.29
      (1.71%)
      Closed July 02 4:00PM
      Delayed by 15 minutes
      136.27
      0.05
      (0.04%)
      After Hours: 5:30PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      ASND News

      Official News Only

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 18 2024
      ASND (1.71%)

      Form 8-K/A - Current report: [Amend]
      Edgar (US Regulatory)
      June 12 2024
      ASND (1.71%)

      Form 424B5 - Prospectus [Rule 424(b)(5)]
      Edgar (US Regulatory)
      June 12 2024
      ASND (1.71%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 11 2024
      ASND (1.71%)

      Form DEF 14A - Other definitive proxy statements
      Edgar (US Regulatory)
      June 05 2024
      ASND (1.71%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 03 2024
      ASND (1.71%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 03 2024
      ASND (1.71%)

      ASND Discussion

      View Posts
      Monksdream Monksdream 4 months ago
      ASND new 52=week high
      👍️0
      Monksdream Monksdream 4 months ago
      ASND new 52 week high
      👍️0
      MiamiGent MiamiGent 5 months ago
      What goes down, must go up :)
      Hope you banked, monk.
      👍️0
      Monksdream Monksdream 5 months ago
      ASND new 52 week high
      👍️0
      Monksdream Monksdream 6 months ago
      ASND new 52 week high
      👍️0
      MiamiGent MiamiGent 1 year ago
      ASND 161 shares traded in pre-mkt. Take your profits- nobody going to hold up this dilution candidate.
      Bearish
      👍️0
      MiamiGent MiamiGent 1 year ago
      ASND After just one day of wooing, ASND is FALLING ...........in love with my short.
      Irresistible attraction: fourteen-month delay on average, need for more money and a red market with housing assuring further rate increase.
      Quote as of 5/02/2023 2:44PM ET
      $86.375 -$0.365 (-0.421%)
      Bearish
      https://www.bing.com/videos/search?q=you+tube+music+roy+orbison+i%27m+falling&view=detail&mid=17436B40AE02F042D00317436B40AE02F042D003&FORM=VIRE
      👍️0
      MiamiGent MiamiGent 1 year ago
      $ASND
      A complete response letter (CRL) from the FDA delays a product’s entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them.
      FDA NEWS
      Bearish
      👍️0
      MiamiGent MiamiGent 1 year ago
      ASND Net Income -$622,419,000 in 2022

      Anyone want to venture a guess when the raise will come?

      I'll take a WAG and say within two weeks.
      👍️0
      MiamiGent MiamiGent 1 year ago
      ASND Quote as of 5/02/2023 10:14AM ET

      $88.07 +$1.33 (+1.533%)

      I'm down -3.22% on my short. Did not choose well- 100% owned by institutions.. not easily budged.
      I am counting on red days, 3 day rule, CRL and outside chance of a raise- it's all I got, lol

      https://stockcharts.com/h-sc/ui?s=ASND
      👍️0
      MiamiGent MiamiGent 1 year ago
      Short today at 85.34

      How long will this languish before possible good news?

      Will need to raise more $$
      👍️0
      crudeoil24 crudeoil24 3 years ago
      Ascendis Pharma: FDA Approves Skytrofa to Treat Pediatric Growth Hormone Deficiency > ASND
      3:46 pm ET August 25, 2021

      By Stephen Nakrosis

      Ascendis Pharma A/S on Wednesday said the U.S. Food and Drug Administration approved its Skytrofa as a treatment for Pediatric Growth Hormone Deficiency.

      The company said Skytrofa, or lonapegsomatropin-tcgd, is the first once-weekly treatment approved to treat Pediatric Growth Hormone Deficiency.

      The company also said Skytrofa was approved to treat "pediatric patients one year and older who weigh at least 11.5 kg and have growth failure due to inadequate secretion of endogenous growth hormone."

      The company said the approval includes its Skytrofa Auto-Injector and cartridges, which enable families to store the medicine at room temperature for up to six months.

      The company said availability of Skytrofa in the U.S. is expected soon.

      Ascendis said it would hold an investor conference call at 4:30 p.m. ET today.


      Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
      👍️0
      crudeoil24 crudeoil24 3 years ago

      ASCENDIS PHARMA A/S is a Danish-based biopharmaceutical company, which is involved in manufacture products for rare diseases. The Company utilizes its TransCon technologies for treatment, which can be applied to existing drug therapies, including proteins, peptides and small molecules, to create prodrugs. The Company is headquartered in Copenhagen, Denmark with offices in Heidelberg, Germany and Palo Alto, California.
      👍️0

      Your Recent History

      NASDAQ
      ASND
      Ascendis Pharma AS
      TSX
      ISCB
      IA Clarington Strategic ...
      Delayed Upgrade Clock